GSK 692342
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK 692342, covering 2019-03-22 to 2019-03-22. Get the full timeline:
Most recent: Clinical Trial Update: Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 [Phase 2]